MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration

microRNAs (miRNA, miR) play an important role in cancer cell growth and migration; however, the potential roles of miRNAs in osteosarcoma remain largely uncharacterized. By applying a miRNA microarray platform and unsupervised hierarchical clustering analysis, we found that several miRNAs have altered expression levels in osteosarcoma cell lines and tumor tissues when compared with normal human osteoblasts. Three miRNAs, miR-199a-3p, miR-127-3p, and miR-376c, were significantly decreased in osteosarcoma cell lines, whereas miR-151-3p and miR-191 were increased in osteosarcoma cell lines in comparison with osteoblasts. Transfection of precursor miR-199a-3p into osteosarcoma cell lines significantly decreased cell growth and migration, thus indicating that the inhibition effect is associated with an increase in the G1-phase and a decrease of the S-phase cell population. In addition, we observed decreased mTOR and Stat3 expression in miR-199a-3p transfected cells. This study provides new insights for miRNAs in osteosarcoma and suggests that miR-199a-3p may play a functional role in osteosarcoma cell growth and proliferation. Restoring miR-199a-3p's function may provide therapeutic benefits in osteosarcoma. Mol Cancer Ther; 10(8); 1337–45. ©2011 AACR.

[1]  A. Palmieri,et al.  Comparison between osteoblasts derived from human dental pulp stem cells and osteosarcoma cell lines , 2008, Cell biology international.

[2]  Thomas D. Schmittgen,et al.  Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival , 2008, Clinical Cancer Research.

[3]  D. Epstein,et al.  Targeting of Integrin β1 and Kinesin 2α by MicroRNA 183* , 2009, The Journal of Biological Chemistry.

[4]  H. Blau,et al.  Tumor suppression by RNA from the 3' untranslated region of alpha-tropomyosin. , 1993, Cell.

[5]  K. Kelnar,et al.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. , 2011, Nature medicine.

[6]  Feng-jun Wang,et al.  Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. , 2010, Gynecologic oncology.

[7]  J. Qu,et al.  MicroRNA-1/206 Targets c-Met and Inhibits Rhabdomyosarcoma Development* , 2009, The Journal of Biological Chemistry.

[8]  George A. Calin,et al.  MicroRNAs — the micro steering wheel of tumour metastases , 2009, Nature Reviews Cancer.

[9]  A. Kolokythas,et al.  Downregulation of the Rho GTPase signaling pathway is involved in the microRNA‐138‐mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma , 2010, International journal of cancer.

[10]  W. De,et al.  Functional and biological analysis of Bcl-xL expression in human osteosarcoma. , 2010, Bone.

[11]  G. Tsujimoto,et al.  Identification of novel microRNA targets based on microRNA signatures in bladder cancer , 2009, International journal of cancer.

[12]  G. Merlino,et al.  MicroRNA reexpression as differentiation therapy in cancer. , 2009, The Journal of clinical investigation.

[13]  Jonathan A. Lee,et al.  A Quantitative, Facile, and High-Throughput Image-Based Cell Migration Method Is a Robust Alternative to the Scratch Assay , 2011, Journal of biomolecular screening.

[14]  P. Comoglio,et al.  MicroRNAs impair MET-mediated invasive growth. , 2008, Cancer research.

[15]  T O Nielsen,et al.  MicroRNA expression signature of human sarcomas , 2008, Oncogene.

[16]  Thomas Tuschl,et al.  miRNAs in human cancer , 2011, The Journal of pathology.

[17]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[18]  J. Bradner,et al.  SD-1029 Inhibits Signal Transducer and Activator of Transcription 3 Nuclear Translocation , 2006, Clinical Cancer Research.

[19]  R. Gorlick,et al.  Novel therapeutic agents for osteosarcoma , 2009, Expert review of anticancer therapy.

[20]  C. Harris,et al.  Genetic variation in microRNA networks: the implications for cancer research , 2010, Nature Reviews Cancer.

[21]  S. Bielack,et al.  Osteosarcoma: the same old drugs or more? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  C. Croce,et al.  MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. , 2010, Cancer research.

[23]  Ji Young Kim,et al.  MicroRNA miR-199a* Regulates the MET Proto-oncogene and the Downstream Extracellular Signal-regulated Kinase 2 (ERK2)* , 2008, Journal of Biological Chemistry.

[24]  C. Croce,et al.  MicroRNA signatures in human ovarian cancer. , 2007, Cancer research.

[25]  Helen M. Blau,et al.  Tumor suppression by RNA from the 3′ untranslated region of α-tropomyosin , 1993, Cell.

[26]  J. Uney,et al.  Twist-1 regulates the miR-199a/214 cluster during development , 2008, Nucleic acids research.

[27]  A. Palmieri,et al.  A comparison between genetic portraits of normal osteoblasts and osteosarcoma cell lines. , 2009, Indian journal of dental research : official publication of Indian Society for Dental Research.

[28]  S. Grant,et al.  Targeting multiple arms of the apoptotic regulatory machinery. , 2007, Cancer research.

[29]  James B. Mitchell,et al.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. , 1987, Cancer research.

[30]  R. Xavier,et al.  Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA‐1 in Met expression , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[31]  F. Denizot,et al.  Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. , 1986, Journal of immunological methods.